Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kobayashi Pharmaceutical CoKBYPF -2.71%81 PE Ratio (TTM) is 117.01 as of Jul. 22, 2026, which is 236% above its 10-year median of 34.86. GuruFocus rates KBYPF with a GF Score™ of 81/100 and a GF Value™ of $35.48. The stock has 5 warning signs investors should review. Among 1,428 Consumer Packaged Goods companies, Kobayashi Pharmaceutical Co ranks worse than 95.8% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-22), Kobayashi Pharmaceutical Co's share price is
$34.05.
Kobayashi Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.29. Therefore, Kobayashi Pharmaceutical Co's PE Ratio (TTM) for today is 117.01.
Warning Sign:
Kobayashi Pharmaceutical Co Ltd stock PE Ratio (=112.36) is close to 10-year high of 123.46.
The historical rank and industry rank for Kobayashi Pharmaceutical Co's PE Ratio (TTM) or its related term are showing as below:
KBYPF'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 18.49 Med: 34.86 Max: 133.89
Current: 133.89
During the past 13 years, the highest PE Ratio (TTM) of Kobayashi Pharmaceutical Co was 133.89. The lowest was 18.49. And the median was 34.86.
KBYPF's PE Ratio (TTM) is ranked worse than 95.8% of 1428
companies
in the Consumer Packaged Goods industry
Industry Median: 15.855
vs KBYPF: 133.89
During the past 12 months, Kobayashi Pharmaceutical Co's average EPS without NRIGrowth Rate was -14.60% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was -5.30% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was -1.70% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 4.70% per year.
During the past 13 years, Kobayashi Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 19.90% per year. The lowest was -13.40% per year. And the median was 1.00% per year.
Kobayashi Pharmaceutical Co (OTCPK:KBYPF) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Kobayashi Pharmaceutical Co PE Ratio (TTM) Related Terms
Kobayashi Pharmaceutical Co PE Ratio (TTM) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Kobayashi Pharmaceutical Co's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kobayashi Pharmaceutical Co PE Ratio (TTM) vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Kobayashi Pharmaceutical Co's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Kobayashi Pharmaceutical Co's PE Ratio (TTM) falls into.
Kobayashi Pharmaceutical Co PE Ratio (TTM) Calculation
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Kobayashi Pharmaceutical Co's Share Price of today is $34.05.
Kobayashi Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.29.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Kobayashi Pharmaceutical Co (KBYPF) has a PE Ratio (TTM) of 117.01 as of Jul. 22, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Kobayashi Pharmaceutical Co and its competitors. This is 236% above median its historical median of 34.86. Over the past decade, Kobayashi Pharmaceutical Co's PE Ratio (TTM) has ranged from 18.49 to 133.89. According to the industry distribution chart, Kobayashi Pharmaceutical Co ranks #1368 out of 1428 companies in the Consumer Packaged Goods industry, placing it in the top 95.8%.
Is Kobayashi Pharmaceutical Co's PE Ratio (TTM) too high?
Kobayashi Pharmaceutical Co's current PE Ratio (TTM) of 117.01 is 236% above median its 10-year median of 34.86. Over the past 10 years, this metric has ranged from a low of 18.49 to a high of 133.89. The Consumer Packaged Goods industry median PE Ratio (TTM) is 15.86. Kobayashi Pharmaceutical Co's value of 117.01 is 638% above this industry median. Based on the distribution chart, Kobayashi Pharmaceutical Co ranks #1368 out of 1428 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Kobayashi Pharmaceutical Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Kobayashi Pharmaceutical Co's PE Ratio (TTM) compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Kobayashi Pharmaceutical Co ranks #1368 out of 1428 companies for PE Ratio (TTM). This places Kobayashi Pharmaceutical Co in the lower half of its industry. The industry median PE Ratio (TTM) is 15.86. Kobayashi Pharmaceutical Co's value of 117.01 is 638% above this benchmark. Historically, Kobayashi Pharmaceutical Co's own PE Ratio (TTM) has ranged from 18.49 to 133.89 over the past decade. While the company's 10-year median is 34.86 vs. the industry median of 15.86, Kobayashi Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Consumer Packaged Goods company?
The median PE Ratio (TTM) among Consumer Packaged Goods companies is 15.86, based on 1,428 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kobayashi Pharmaceutical Co's current PE Ratio (TTM) of 117.01 is 638% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Kobayashi Pharmaceutical Co and its competitors. For the Consumer Packaged Goods industry, the median PE Ratio (TTM) is 15.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kobayashi Pharmaceutical Co's current PE Ratio (TTM) is 117.01, which is 236% above median its own 10-year median of 34.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kobayashi Pharmaceutical Co stock overvalued right now?
Kobayashi Pharmaceutical Co (KBYPF) has a current PE Ratio (TTM) of 117.01. The stock's GF Value™ is $35.48, compared to a current price of $34.05 — trading 4% below its estimated fair value. The current PE Ratio (TTM) is 117.01, which is 236% above median its 10-year median of 34.86 and 638% above the Consumer Packaged Goods industry median of 15.86. Kobayashi Pharmaceutical Co's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Kobayashi Pharmaceutical Co (KBYPF), the current PE Ratio (TTM) is 117.01 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kobayashi Pharmaceutical Co (KBYPF) Overvalued in 2026?
Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co stock appears to be undervalued.
The current stock price of $34.05 is trading 4% below its estimated GF Value™ of $35.48.
Key valuation signals for KBYPF:
PE Ratio (TTM): 117.01 (236% above median its 10-year median of 34.86)
GF Value™: $35.48 vs. price of $34.05 (4% below fair value)
Industry Position: 638% above the Consumer Packaged Goods median (#1368 of 1428)
No single metric tells the full story. See the KBYPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kobayashi Pharmaceutical Co Ltd is engaged in the manufacture and sale of healthcare products, daily necessities, and body warmers. The company operates through two reportable segments: Domestic Business and International Business, which handle production and sales activities in Japan and overseas, respectively. The company's product portfolio includes disposable body warmers, cooling gel sheets, OTC pharmaceuticals, oral hygiene products, air fresheners, eyeglass wipes, and deodorizing/household sundries.
81GF Score
Get the complete analysis for KBYPF
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KBYPF has been successfully added to your 
